Skip to main contentSkip to navigation
Sirius Investors
HUTCHMED (China) Limited

HUTCHMED (China) Limited

HCM
NASDAQHealthcare

HUTCHMED (China) Limited (HCM) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate HUTCHMED (China) Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
5.00
Strong
WeakModerateStrong
P/B Ratio
1.88
Strong
WeakModerateStrong
Earnings Yield
19.63%
Strong
WeakModerateStrong

Profitability Health

2025
Return on Equity
36.91%
Strong
WeakModerateStrong
Operating Margin
-7.14%
Weak
WeakModerateStrong
Net Profit Margin
83.30%
Strong
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
-12.73%
Weak
WeakModerateStrong
Net Income Growth
1114.23%
Strong
WeakModerateStrong
EPS Growth
1101.81%
Strong
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
4.96
Strong
WeakModerateStrong
Quick Ratio
4.83
Strong
WeakModerateStrong
Asset Turnover
0.31x
Weak
WeakModerateStrong
Inventory Turnover
11.79x
Strong
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
-3.39%
Weak
WeakModerateStrong
EV / Free Cash Flow
-29.83x
Strong
WeakModerateStrong
Net Debt / EBITDA
-1.03x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-13.313
Weak
WeakModerateStrong
Return on Invested Capital
-2.35%
Weak
WeakModerateStrong
Cash Conversion Cycle
95.04 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HCM.

View Financial Statements